EGFR and neoplasm: Unfortunately, acquisition of the EGFR T790M missense mutation, occurring in 50% of NSCLC, was found to cause structural changes in the EGFR binding pocket, thus rendering tumor cells resistant to the second generation of TKIs and requiring new treatments [49].